| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| IL-10 | HOT IL0-H5219 | Human IL-10 Protein, premium grade | Human | HEK293 | ![]() | MALSSDS-PAGE | $355.00 20ug | ||
| IL-10 | HOT IL0-H4248 | Human IL-10 Protein, His Tag | Human | HEK293 | ![]() | SDS-PAGE | $205.00 20ug | ||
| IL-10 | HOT GMP-L10H25 | GMP Human IL-10 Protein | Human | HEK293 | ![]() | SDS-PAGE | $1165.00 50ug | ||
| IL-10 | Cynomolgus IL-10 Protein, His Tag | Cynomolgus | HEK293 | ![]() | SDS-PAGE | $165.00 20ug | |||
| IL-10 | Human IL-10 Protein, Research Grade | Human | HEK293 | ![]() | MALSSDS-PAGE | $219.00 20ug | |||
| IL-10 | Avitag IL0-H82Q3 | Biotinylated Human IL-10 Protein, His,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $368.00 25ug | ||
| IL-10 | Mouse IL-10 Protein, His Tag | Mouse | HEK293 | ![]() | SDS-PAGE | $165.00 20ug |
| Project Name | Drug Type | Therapeutic Area | Indication | Stage | Rights Area |
|---|---|---|---|---|---|
| IL10 / IL10RA mAb | Monospecific antibody | Infectious and parasitic diseases | Immunodeficiencies | PCC | Global |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| SFA-002 | SFA-002; SFA002 | Phase 3 Clinical | SFA Therapeutics Inc | Arthritis, Rheumatoid; Plaque psoriasis; Psoriasis | Details |
| Mesenchymal stem cells therapy (Therapeutic Solutions International) | Phase 3 Clinical | Jadi Cell LLC | Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult | Details | |
| KLS-2031 | KLS-2031 | Phase 2 Clinical | Kolon Life Science. Inc | Neuralgia; Radiculopathy | Details |
| WP-1303 (worgpharma) | ATX-MS-1467; ATX-MS-01; M-2736; WP-1303; MSC-2358825A | Phase 2 Clinical | Apitope Technology | Multiple Myeloma; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting | Details |
| TRX-103 | TRX-103; TRX103 | Phase 2 Clinical | Tr1X Inc | Crohn Disease; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic stem cell transplantation (HSCT); Inflammatory Bowel Diseases; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Uveitis | Details |
| Faecalibacterium prausnitzii EXL01 (Exeliom) | EXL-01; EXL01 | Phase 2 Clinical | Exeliom Biosciences | Bacterial Infections; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Clostridium Infections; Crohn Disease; Stomach Neoplasms | Details |
| XT-150 | XT-101; XT-150; XT-101-R | Phase 2 Clinical | Xalud Therapeutics Inc | Amyotrophic Lateral Sclerosis; Arthralgia; Back Pain; Inflammation; Multiple Sclerosis; Neuralgia; Osteoarthritis, Knee; Osteoarthritis, Spine | Details |
| Anti-CD19 IL10 CAR-NK cell therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine) | Phase 1 Clinical | Second Affiliated Hospital School Of Zhejiang University School Of Medicine | Lymphoma, B-Cell | Details | |
| FP-008 (Fapon Biotech) | FP-008; FP008 | Phase 1 Clinical | Guangdong Fapon Biopharma Inc | Neoplasms; Solid tumours | Details |
